SCHEMBL18909339

SCHEMBL18909339

CCC(=O)N1CCC(N2CCN(C)C(=O)C2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
EPHX2 P34913 3/20 0.39
ACACB O00763 2/20 0.39
ACACA Q13085 2/20 0.39
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
ACHE P22303 4/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
RECQL P46063 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AOC3 Q16853 1/20 0.37
PDE7A Q13946 1/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.36
HIF1A Q16665 1/20 0.36
L3MBTL3 Q96JM7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22891630 0.89 KDM4E (0.40) KDM4ECYP2C9CYP2C19ACACBACACA
SCHEMBL22030907 0.85 KDM4E (0.58) KDM4ECYP2C9CYP2C19EPHX2ACACB
SCHEMBL18667743 0.79 PIK3CD (0.41) LMNAAOC3PDE7A
SCHEMBL18023766 0.78 KMT2A (0.47) ACHESMN1; SMN2AOC3PDE7AMAPT
SCHEMBL18909112 0.78 ACHE (0.51) KDM4ECYP2C9CYP2C19EPHX2ACACB
SCHEMBL13472648 0.77 DPP4 (0.47) LMNAGAAALDH1A1
SCHEMBL13395700 0.77 L3MBTL1 (0.40) CHRM2GAASMN1; SMN2AOC3PDE7A
SCHEMBL25809468 0.76 PIK3CD (0.39) RECQLSMN1; SMN2AOC3PDE7AMAPT
SCHEMBL18656058 0.76 SETD2 (0.41) LMNAAOC3PDE7A
SCHEMBL18909099 0.75 HRH3 (0.47) KDM4ECYP2C9CYP2C19EPHX2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed